Catherine Bouvier

Royal Leamington Spa, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients.

Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients.

Journal: Journal of neuroendocrinology

Published: March 13, 2023

Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population-based study.

Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population-based study.

Journal: The Lancet regional health. Europe

Published: September 30, 2022

The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients.

The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients.

Journal: Journal of neuroendocrinology

Published: March 10, 2022

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN.

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN.

Journal: ESMO open

Published: March 02, 2021

The Role of Patient Support Groups in Neuroendocrine Neoplasms.

The Role of Patient Support Groups in Neuroendocrine Neoplasms.

Journal: Current oncology reports

Published: February 12, 2021

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 24, 2020

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era.

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 01, 2020

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Journal: International journal of cancer

Published: April 26, 2019

Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015.

Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015.

Journal: British journal of cancer

Published: January 22, 2019

Prevalence of self-reported side effects in neuroendocrine tumour patients prescribed somatostatin analogues.

Prevalence of self-reported side effects in neuroendocrine tumour patients prescribed somatostatin analogues.

Journal: British journal of nursing (Mark Allen Publishing)

Published: July 12, 2018

Delays and routes to diagnosis of neuroendocrine tumours.

Delays and routes to diagnosis of neuroendocrine tumours.

Journal: BMC cancer

Published: May 15, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026